Knomiks Overview

  • Founded
  • 2014
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Knomiks General Information

Description

Developer of biomedical drugs created to target gut microbiota. The company's biomedical drugs are used in the investigation of bacterial populations, which determine the metabolism of many nutrients and vitamins, forming the immune system and resist diseases, enabling physicians to identify and provide early treatment for the intestinal problems in human caused by microbiota.

Contact Information

Website
www.knomics.ru
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Parent Company
Atlas Biomedical Holding
Primary Office
  • D. 3a Street. 2
  • Semenovskaya M
  • Moscow, 107023
  • Russia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Knomiks Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Knomiks‘s full profile, request access.

Request a free trial

Knomiks Executive Team (2)

Name Title Board Seat Contact Info
Dmitry Alexeev Ph.D General Director
Dmitry Alexeyev Founder
To view Knomiks’s complete executive team members history, request access »

Knomiks Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Knomiks‘s full profile, request access.

Request a free trial